Atossa Therapeutics Inc (ATOS)
1.69
+0.01
(+0.60%)
USD |
NASDAQ |
May 09, 16:00
1.685
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Price to Book Value: 2.327 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.327 |
| May 08, 2024 | 2.313 |
| May 07, 2024 | 2.340 |
| May 06, 2024 | 2.368 |
| May 03, 2024 | 2.285 |
| May 02, 2024 | 2.093 |
| May 01, 2024 | 2.106 |
| April 30, 2024 | 2.079 |
| April 29, 2024 | 2.106 |
| April 26, 2024 | 2.106 |
| April 25, 2024 | 2.093 |
| April 24, 2024 | 2.065 |
| April 23, 2024 | 2.051 |
| April 22, 2024 | 1.955 |
| April 19, 2024 | 1.886 |
| April 18, 2024 | 1.955 |
| April 17, 2024 | 1.859 |
| April 16, 2024 | 2.120 |
| April 15, 2024 | 2.354 |
| April 12, 2024 | 2.285 |
| April 11, 2024 | 2.437 |
| April 10, 2024 | 2.409 |
| April 09, 2024 | 2.533 |
| April 08, 2024 | 2.409 |
| April 05, 2024 | 2.574 |
| Date | Value |
|---|---|
| April 04, 2024 | 2.891 |
| April 03, 2024 | 2.788 |
| April 02, 2024 | 2.533 |
| April 01, 2024 | 2.754 |
| March 28, 2024 | 2.478 |
| March 27, 2024 | 2.519 |
| March 26, 2024 | 2.478 |
| March 25, 2024 | 2.602 |
| March 22, 2024 | 2.299 |
| March 21, 2024 | 2.313 |
| March 20, 2024 | 2.244 |
| March 19, 2024 | 2.134 |
| March 18, 2024 | 1.776 |
| March 15, 2024 | 1.776 |
| March 14, 2024 | 1.635 |
| March 13, 2024 | 1.716 |
| March 12, 2024 | 1.784 |
| March 11, 2024 | 1.635 |
| March 08, 2024 | 1.485 |
| March 07, 2024 | 1.498 |
| March 06, 2024 | 1.567 |
| March 05, 2024 | 1.390 |
| March 04, 2024 | 1.390 |
| March 01, 2024 | 1.362 |
| February 29, 2024 | 1.331 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5132
Minimum
Dec 28 2022
11.41
Maximum
Feb 04 2021
1.858
Average
1.150
Median
Jul 08 2019
Price to Book Value Benchmarks
| AngioDynamics Inc | 1.119 |
| Achieve Life Sciences Inc | -- |
| Biolase Inc | -- |
| Outset Medical Inc | 1.344 |
| Perspective Therapeutics Inc | 14.05 |
Price to Book Value Related Metrics
| Price | 1.69 |
| Earnings Yield | -14.20% |
| Market Cap | 211.76M |